Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
September 22, 2016
WASHINGTON—Pamela Forrest has joined Covington in its Food, Drug, and Device practice, resident in Washington.
Ms. Forrest has more than 20 years of experience advising clients on a broad range of FDA regulatory issues. Her practice focuses on FDA medical device matters, including premarket review, product recalls, medical device reporting (MDR), Quality System Regulation (QSR) compliance, labeling and promotion, import/export issues, and clinical trial requirements. She has extensive experience working with device manufacturers on responding to FDA enforcement actions, including Form FDA-483 observations and Warning Letters. In addition, Ms. Forrest frequently assists medical device manufacturers, investment banks, and private equity funds with due diligence evaluations of FDA-regulated companies.
“We are pleased to welcome Pam to Covington’s Food, Drug & Device Practice Group,” said Denise Esposito, co-chair of the firm’s FDA regulatory practice. “Pam’s extensive experience in the medical device space and her deep knowledge of the device regulatory landscape will provide our clients with a strong resource for regulatory and strategic advice relating to the development and marketing of existing and novel medical products.”
“I am excited to join Covington’s medical device practice,” said Ms. Forrest. “Helping clients overcome seemingly insurmountable regulatory obstacles on the path to market is especially gratifying.”
Ms. Forrest received a B.A. in Political Science summa cum laude, Phi Beta Kappa, from Yale University and a J.D. from Stanford Law School.
Covington represents many of the world’s leading medical technology and biopharmaceutical companies. Together with leading practitioners in Europe and Asia, Covington advises medical device clients on a global basis with respect to their most challenging legal, regulatory, and compliance matters.